Core Laboratories Inc

Core Laboratories NV engages in the provision of proprietary and patented reservoir description, production enhancement, and reservoir management services to the oil and gas industry. It operates through the following business segments: Reservoir Description and Production Enhancement. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid, and gas samples and provides analytical and field services to characterize properties of crude oil and petroleum products. The Production Enhancement segment provides products and services relating to reservoir well completions, perforations, stimulations, and production. The company was founded in 1936 and is headquartered in Amsterdam, the Netherlands.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Core Labs reports strong Q4 performance, eyes growth opportunities

Core Laboratories Inc delivered a solid performance in Q4 2022, focusing on financial strength, operational efficiency, and future growth prospects. Despite facing challenges from external factors, the company remains optimistic about opportunities in the energy sector and its ability to create value for shareholders.

Core Laboratories Inc reports robust Q1 earnings, eyes EOR opportunities

Core Laboratories Inc delivered strong financial results, highlighted operational efficiencies, and outlined growth strategies amidst industry challenges. The company's focus on innovation, debt reduction, and cost savings bodes well for future performance and shareholder value.

Core Labs reports solid Q2 performance, eyes international growth

Core Laboratories Inc showcased strong financial performance in Q2 2023, with a focus on operational efficiency and technological advancement.
The company's commitment to maximizing free cash flow, returns on invested capital, and shareholder value underscores its financial discipline and strategic priorities.
Despite challenges in the US land sector, Core Labs remains optimistic about international growth opportunities and technological advancements driving future success.

Core Laboratories Inc reports strong Q3 performance amidst market challenges

Core Laboratories Inc delivered a strong Q3 performance with improvements in key financial metrics. While facing challenges in certain segments, the company's strategic focus on innovation and efficiency positions it well for future opportunities. Core Labs remains optimistic about its outlook and is committed to driving growth and value for shareholders.

Core Laboratories reports steady Q4 performance amidst operational challenges

Core Laboratories navigated challenges in Q4 with a focus on debt reduction, innovation, and operational excellence, showcasing resilience and adaptability.
While facing headwinds in certain segments, Core Labs remains committed to long-term sustainability, shareholder value, and technological advancement.
Strategic initiatives and operational highlights underscore Core's leadership in the industry, setting the stage for future growth and market expansion.

Core Labs maintains steady performance amidst geopolitical challenges and debt reduction

Core Laboratories Inc delivered a resilient performance in Q1 2024, focusing on operational efficiency and debt reduction amidst external challenges.
The company's strategic strengths lie in international growth prospects, technology investments, and commitment to financial stability.
Challenges from geopolitical conflicts and operational disruptions highlight the need for adaptability and diversification in Core Labs' business approach.
Opportunities abound in capitalizing on international growth, technology advancements, and maximizing return on invested capital for sustainable growth.

Core Laboratories reports revenue growth and debt reduction in Q3

Core Laboratories Inc delivered a solid financial performance in Q3 2024, with revenue growth, improved margins, and reduced debt levels.
While facing challenges in a competitive market and capital expenditure constraints, the company remains focused on sustaining profitability and operational efficiency.
Opportunities lie in leveraging segment revenue growth, debt reduction strategies, and exploring new avenues for expansion and partnerships.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Core Laboratories Inc. provides proprietary and patented reservoir description and production enhancement services. The company was founded on May 1, 2023 and is headquartered in Houston, TX.

Core Laboratories N.V. presents itself as one of the leading providers of reservoir description and production enhancement services. The company will be able to use its cash in hand to hire more personnel as well as develop new versions of the Reservoir Optimized Completions Lab.

Core Laboratories: New Services And M&A Could Make The Stock Spike Up

Centennial Resource Development

Hess Midstream Partners

Ring Energy

Tellurian

Multiple developments sent oil and gas prices crashing, but investors should look at the big picture.

Why Oil and Gas Stocks Slumped on Wednesday

AMSTERDAM, Sept. 27, 2021 /PRNewswire/ -- Core Laboratories (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") will broadcast its third quarter 2021 conference call over the Internet at 7:30 a.m.

Core Laboratories' Third Quarter 2021 Webcast At 7:30 a.m. CDT / 2:30 p.m.

Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock?

Why Is Core Laboratories (CLB) Down 19.4% Since Last Earnings Report?

Ballard Power Systems

Clean Energy Fuels

Enovix Corporation

Occidental Petroleum

Multiple developments in the energy sector are sending stocks higher.

Why Oil and Renewable Energy Stocks Are Soaring This Week

Peabody Energy

Higher oil and gas prices are refueling investor interest in these stocks.

Why Shares of Centennial Resource, Core Labs, and Peabody Energy Are on Fire Today

Phillips 66

Energy stocks took it on the chin this week.

Why Energy Stocks Are Down This Week

In the June quarter, Core Labs (CLB) generates $9.5 million in operating cash and its capital expenditure totals $2.9 million, leading to a $6.6-million free cash flow (FCF) recognition.

Core Labs' (CLB) Q2 Earnings and Revenues Miss Estimates

Core Laboratories N.V. (CLB) CEO Larry Bruno on Q2 2021 Results - Earnings Call Transcript

There were some bright spots in the quarterly earnings report, but investors don't seem to care.

Why Shares of Core Laboratories Are Falling Today

Core Laboratories (CLB) delivered earnings and revenue surprises of -5.26% and -0.09%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Core Laboratories (CLB) Lags Q2 Earnings and Revenue Estimates

AMSTERDAM, July 28, 2021 /PRNewswire/ -- Core Laboratories N.V. (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") ("Core", "Core Lab", or the "Company") reported second quarter 2021 revenue of $118,700,000.

Core Lab Reports Second Quarter 2021 Results From Continuing Operations:

Transocean

This trio of energy names got a boost when a key commodity hit an equally key price level.

Why Core Labs, Centennial Resource Development, and Transocean Popped in Early Trading Today

AMSTERDAM, June 29, 2021 /PRNewswire/ -- Core Laboratories (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") will broadcast its second quarter 2021 conference call over the Internet at 7:30 a.m. CDT / 2:30 p.m.

Core Laboratories' Second Quarter 2021 Webcast At 7:30 A.M. CDT / 2:30 P.M.

The oilfield services stock has cooled off after a big run.

Why Core Labs Stock Slumped This Week

Chipotle

Kinder Morgan

Wendy's

Autolus Therapeutics

Cheniere Energy Partners

CRISPR Therapeutics

DHI Group

EnLink Midstream

iMedia Brands

Tyler Technologies

Welltower

Monday's futures were relatively flat, with the Nasdaq looking the best out of the group with about a 0.2% gain.

Monday's Analyst Upgrades and Downgrades: Chipotle, CRISPR, Hess Midstream, iMedia, Kinder Morgan, Wendy's and More

Oceaneering

Several catalysts fueled a rally in the energy market this week.

Why Energy Stocks Are Up Big This Week

TechnipFMC

Liberty Oilfield Services

NexTier Oilfield Solutions Inc

Schlumberger

An industry leader is getting increasingly bullish on the oil and gas sector.

Why These Oil Stocks Are Soaring Today

Core Laboratories (CLB) Up 33.5% Since Last Earnings Report: Can It Continue?

CLB's Q1 revenue fell 5% sequentially. North America land drilling continued to show signs of life. Cost-containment efforts kept EBITDA margins in the double-digit percentage range.

Core Laboratories: The Upside Appears Priced In

Core Laboratories NV (CLB) CEO Lawrence Bruno on Q1 2021 Results - Earnings Call Transcript

In the March quarter, Core Labs (CLB) generates $8 million in operating cash and its capital expenditure totals $2.8 million, leading to a $5.2-million free cash flow (FCF) recognition.

Core Labs' (CLB) Q1 Earnings Beat Estimates, Revenues Miss

Core Laboratories (CLB) delivered earnings and revenue surprises of 15.38% and -1.61%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Core Laboratories (CLB) Q1 Earnings Top Estimates

Shares of Core Laboratories (NYSE:CLB) were flat in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share fell 51.61% over the past year to $0.15, which beat the estimate of $0.13.

Recap: Core Laboratories Q1 Earnings

AMSTERDAM, April 21, 2021 /PRNewswire/ -- Core Laboratories N.V. (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") ("Core", "Core Lab", or the "Company") reported continuing operations resulted in first quarter 2021 revenue of $108,400,000.

News for Core Laboratories Inc Stock (CLB)